Rutao Wang

Showing 1-4 of 4 articles

Interventions for valvular disease

Valvular heart interventions: advances from 2019 to 2020

Wang R, Gao C, Kawashima H, Modolo R, Rosseel L, Onuma Y, Soliman O, Serruys P, Mylotte D

September 22, 2020 | 10.4244/EIJ-D-20-00096

Coronary interventions

A randomized controlled trial to compare the safety and efficacy of sirolimus-eluting biodegradable polymer ultra-thin stent (SUPRAFLEX Cruz) and everolimus-eluting biodegradable polymer stent (SYNERGY) in treatment for three-vessel coronary artery disease: design of the Multivessel TALENT trial

Hara H, Gao C, Kogame N, Ono M, Kawashima H, Wang R, Morel M, O'Leary N, Sharif F, Möllmann H, Reiber J, Sabate M, Zaman A, Wijns W, Onuma Y, Serruys P

September 15, 2020 | 10.4244/EIJ-D-20-00772

The year in review: coronary interventions

Gao C, Wang R, Sharif F, Takahashi K, Ono M, Hara H, Tomaniak M, Kawashima H, Modolo R, van Geuns R, Capodanno D, Byrne R, Wijns W, Onuma Y, Serruys P

April 17, 2020 | 10.4244/EIJ-D-19-01124

Coronary interventions

Impact of the CABG SYNTAX Score on 10-year All-cause Death: Insights from the SYNTAX Extended Survival Study

Takahashi K, Thuijs D, Hara H, Wang R, Mohr F, Morice M, Holmes D, Kappetein AP, Head S, Onuma Y, Serruys P

April 14, 2020 | 10.4244/EIJ-D-20-00170

1

Latest news

Focus on emerging physiology indices, TAVI, sizing with abnormal aortic cusps, a megaregistry of complex PCIs and more…

Hinge point-based aortic annular plane

September 18, 2020

Ahead of print: Histopathology of embolic debris during TAVI

September 18, 2020

Transcatheter VIV implantation for failed surgical bioprostheses

September 18, 2020

VOYAGER PAD, PARTNER 2A, ISCHEMIA and much more

(The Trials book is supported by Biotronik)

August 28, 2020

Over 10,000 followers

September 18, 2020

Steady-state hyperaemia: many routes, one goal

September 18, 2020

This Week's JAA's: Biograde Study, Advances in valvular heart interventions...

September 22, 2020

Valvular disease